Echo IQ Limited (ASX:EIQ)

Market Cap	581.56M +229.4%
Revenue (ttm)	90.91K -30.0%
Net Income	-15.71M
EPS	-0.03
Shares Out	660.86M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	1,166,164
Average Volume	3,100,386
Open	0.8900
Previous Close	0.8800
Day's Range	0.8850 - 0.9150
52-Week Range	0.1650 - 0.9650
Beta	0.24
RSI	65.69
Earnings Date	May 27, 2026

About Echo IQ

Echo IQ Limited engages in the provision of artificial intelligence (AI) diagnostics tool that enhance the diagnosis of structural heart disease in Australia. It offers EchoSolv, provides an AI-powered risk assessment of structural heart disease, including aortic stenosis, diastolic dysfunction, and heart failure. The company was formerly known as Houston We Have Limited and changed its name to EchoIQ Limited in December 2021. Echo IQ Limited is based in Claremont, Australia.

• Industry: Health Information Services
• Sector: Healthcare
• CEO: Dustin Haines
• Country: Australia
• Stock Exchange: Australian Securities Exchange
• Ticker Symbol: EIQ

Financial Performance

In fiscal year 2025, Echo IQ's revenue was 101,409, an increase of 127.89% compared to the previous year's 44,500. Losses were -13.26 million, 145.2% more than in 2024.